NCT07058207Recruiting
Weight Management in Obese Cancer Patients During Curative Active Treatment
Weight Management in Obese Cancer Patients During Curative Active Treatment (CANOBESE Study): A Feasibility Study
Source: ClinicalTrials.gov · Last updated 28 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain. The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 10 Jun 2025
- Start date
- 22 Jul 2025
- Primary completion date
- 31 Aug 2026
- Lead sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Diseases
- Obesity
- NCT number
- NCT07058207
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 22 Jul 2025 to the primary completion date, 31 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Surgery as the only treatment.
- History of bariatric (or LapBand) surgery, or considering or currently on a wait-list for bariatric or LapBand surgery
- Patients with any concurrent medical or psychological condition that, in the investigator's opinion, would jeopardize the safety of the patient or compliance with the protocol.
Other illness
- Tumour localizations with high risk of malnutrition (such as head and neck, upper gastrointestinal tract, or pancreatic cancer):
- Another active malignancy
- Current health or medical condition that affects weight status, e.g., untreated hyper- or hypothyroidism,etc
- Pre-existing medical condition that precludes adherence to unsupervised exercise, e.g., severe orthopedic conditions, scheduled for a hip or knee replacement, bone metastases, paralysis, dementia, untreated stage 3 hypertension, or unstable angina, heart attack, congestive heart failure or conditions that dictated hospitalization or oxygen within 6-months.
- Active suicidal ideation, anorexia, bulimia, binge eating disorder, current substance abuse or dependence (besides nicotine dependence)
Other
- Patients with melanoma and brain tumours.
- Pregnancy or breastfeeding
- Unable to read or understand Spanish or Catalan
- Enrolled in a weight loss program
- Use of pacemaker or another electrical implanted device
Who the study is looking for
- Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with curative intend.
- Expected oncological treatment time ≥ 3 months.
- BMI ≥ 30 kg/m²
- Resident in the Barcelona area up to the completion of cancer treatment.
- ECOG Perfomance Status (PS) 0-1
- Availability of internet access.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Català d'Oncologia. Catalan Institute of Oncology Coordinator of this site? Confirm its status | L'Hospitalet de Llobregat | Spain | Recruiting |
Related publications
- Weight management in obese cancer patients during curative active treatment: protocol for the CANOBESE feasibility study.Pilot Feasibility Stud · 2026 · PMID 42343485
This page is information, not medical advice. Discuss any trial with your doctor.